Genecare Development Limited reduced its holdings in TRANSTHERA-B (02617) by 467,500 shares at a price of approximately HKD 12.58 per share.

According to the latest data from the Hong Kong Stock Exchange, on August 5, Genecare Development Limited reduced its holdings in TRANSTHERA-B (02617) by 467,500 shares, at a price of HKD 12.5786 per share, for a total amount of approximately HKD 5.8805 million. After the divestment, the latest number of shares held is approximately 21,492,900, with a latest holding percentage of 6.87%. This transaction involves other related parties: Chan Tam Ching Fan, Ghalibo (PTC) Limited, Morningside Holdings (Asia) Limited, Morningside Bio-Ventures Limited, Morningside Venture (I) Investments Limited.